MEDICA Newsletter
Social Media
More about…
- 3D-Druck
- Adipositas
- Alkohol
- Allergien
- Alter
- Alzheimer
- Antibiotika
- Arzneimittel
- Asthma
- Augen
- Ausbildung
- Autismus
- Baby
- Behandlung
- Beleuchtung
- Bildgebung
- Biochip
- Biofeedback
- Biokompatibel
- Biomarker
- Biotechnologie
- Blut
- CT
- Chirurgie
- Demenz
- Depression
- Desinfektion
- Diabetes
- Diagnostik
- Elektronische Patientenakte
- Endoprothese
- Epilepsie
- Erbmaterial
- Fitness
- Forschung
- Frauen
- Früherkennung
- Geburt
- Gehirn
- Genetik
- Geräte
- Haut
- Hepatitis
- Herz
- Herz-Kreislauf
- Hygiene
- Immunsystem
- Implantat
- Infektionskrankheit
- Informationstechnologie
- Kinder
- Kommunikation
- Krankenhaus
- Krebs
- Künstliche Intelligenz
- Labor
- Laser
- Lunge
- MRT
- Magen
- Medizinische Apps
- Medizinmarkt
- Mikrosystemtechnik
- Minimal-Invasiv
- Multiple Sklerose
- Nanotechnologie
- Neurologie
- Niere
- Notfallmedizin
- Notrufsysteme
- Operation
- Optimierung
- Optische Technologien
- Organe
- Parkinson
- Pathogene
- Pathologie
- Patienten
- Personalisierte Medizin
- Pflege
- Physiotherapie
- Polymere
- Prothese
- Psychologie
- Qualität
- Radiologie
- Regenerative Medizin
- Rehabilitation
- Risiken
- Robotik
- Röntgengeräte
- SARS-CoV-2/COVID-19
- Schlaganfall
- Schwangerschaft
- Screening
- Sicherheit
- Sinne
- Smart textiles
- Software
- Stammzellen
- Stent
- Sterilisation
- Telemedizin
- Therapie
- Tissue Engineering
- Tuberkulose
- Ultraschall
- Virtual Reality
- Wearables
- Werkstoffe
- Wundheilung
- Zellen
- Ärzte
Blood group co-determines composition of the intestinal microbiome
21/01/2021
Chronic inflammatory bowel disease (CIBD) in particular is suspected to be closely linked to the composition and (im-)balance of the intestinal microbiome. However, the causal relationship between the microbiome and the development of disease and determining factors of the composition of the microbiome in the individual are still largely unexplained.
Detecting COVID-19 antibodies in 10-12 seconds
15/01/2021
Researchers at Carnegie Mellon University report findings on an advanced nanomaterial-based biosensing platform that detects, within seconds, antibodies specific to SARS-CoV-2, the virus responsible for the COVID-19 pandemic. In addition to testing, the platform will help to quantify patient immunological response to the new vaccines with precision.
Vivatmo me: monitor your asthma treatment at home
01/01/2021
Allergic asthma is a chronic disease that makes regular monitoring essential to keep it under control. This is the only way to determine whether the prescribed medication is effective or whether the patient needs a treatment adjustment. Vivatmo me is a breath analyzer device for home use and helps keep asthma patients safe and confident between visits to the doctor.
X-ray study explores potential of hepatitis C drugs to treat COVID-19
17/11/2020
Experiments led by researchers at the Department of Energy's Oak Ridge National Laboratory have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.
Algorithm identifies previously undetected cancer driver genes
13/11/2020
A new study, led by researchers from the University of California, Irvine, has deepened the understanding of epigenetic mechanisms in tumorigenesis and revealed a previously undetected repertoire of cancer driver genes. The study was published this week in Science Advances.
Rapid test can ID unknown causes of infections throughout the body
12/11/2020
UC San Francisco scientists have developed a single clinical laboratory test capable of zeroing in on the microbial miscreant afflicting patients hospitalized with serious infections in as little as six hours -- irrespective of what body fluid is sampled, the type or species of infectious agent, or whether physicians start out with any clue as to what the culprit may be.
Machine learning models to predict critical illness and mortality in COVID-19 patients
11/11/2020
Mount Sinai researchers have developed machine learning models that predict the likelihood of critical events and mortality in COVID-19 patients within clinically relevant time windows. The new models outlined in the study could aid clinical practitioners at Mount Sinai and across the world in the care and management of COVID-19 patients.
Biomarker combination predicts kidney injury in critically ill children
02/11/2020
Researchers at the University of Liverpool have identified a unique method of identifying the early signs of a potentially serious condition known as Acute Kidney Injury (AKI).
Cardiac diagnostics – prompt and personalized
08/11/2019
If physicians suspect an acute myocardial infarction, they first order an ECG. This test is very established and allows cardiologists to quickly diagnose acute heart attacks – though the test does not detect less common heart attack symptoms. So far, those patients had to wait up to twelve hours before a heart attack could be accurately diagnosed or ruled out. But things are about the change.
Early detection: Tattoo signals cancer – and more
09/07/2018
People who are not ill and do not show any symptoms typically do not visit the doctor. And while most people know that preventive medical checkups for cancer, for example, are important, they still avoid them. They tend to be very hesitant because the doctor might detect a serious illness. In the future, a new type of implant could make it easier to go to a screening test.
Personalized cancer medicine – Best possible treatment with TherapySelect
30/04/2018
Medicine is getting more and more personalized. This is particularly interesting for oncology, since a cancer is as individual as the respective patient. When choosing a therapy, both the characteristics of the tumor and the personal characteristics of the patient must be considered. To see exactly what this looks like, we visited the diagnostics company TherapySelect, based in Heidelberg.
Personalized medicine: a paradigm shift is gaining momentum
01/03/2018
Personalized medicine does not follow a "one-size-fits-all" treatment approach but emphasizes a "tailor-made" paradigm, meaning a treatment is customized to each individual person's case. For patients, this increases the chances of treatment success and means fewer side effects. While the approach originates in the field of oncology, it is now also increasingly applied to other disease patterns.